Gagner, Michel http://orcid.org/0000-0001-6068-0333
Article History
Received: 29 August 2021
Revised: 29 August 2021
Accepted: 30 August 2021
First Online: 8 November 2021
Declarations
:
: The author is a consultant for Novo Nordisk and a consultant and stocks owner with Lexington Medical, Inc. and GT Metabolic Solutions, Inc.